Hospitalization risk factors in antipsychotic-treated schizophrenia, bipolar I disorder or major depressive disorder

Journal of Comparative Effectiveness Research

Medication Adherence, Health Care Utilization, and Costs in Patients With Major Depressive Disorder Initiating Adjunctive Atypical Antipsychotic Treatment

Clinical Therapeutics

Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims data

Current Medical Research and Opinion

Lower Medical Cost Associated with Aripiprazole Once-Monthly Compared to Oral Atypical Antipsychotics in Patients with Schizophrenia

AMCP Managed Care and Specialty Pharmacy Annual Meeting